ConductScience.org, home

Genes

Open

193,990 genes from NCBI Gene. Counted 2026-11-11.

193,990 genes

Most papers first481 to 500 of 193,990

Show the results as
GeneNCBI GeneProteinsPatentsDrugsTrialsNIH grantsPapers
VHL

von Hippel-Lindau tumor suppressor

7428

HGNC:12687

155005,85015,284
PROC

protein C, inactivator of coagulation factors Va and VIIIa

5624

HGNC:9451

11492133,22615,233
CD2

CD2 molecule

914

HGNC:1639

12152386,67815,189
PTPN11

protein tyrosine phosphatase non-receptor type 11

5781

HGNC:9644

152127,40815,170
CA2

carbonic anhydrase 2

760

HGNC:1373

1136113237,27515,113
BCL6

BCL6 transcription repressor

604

HGNC:1001

185005,95115,021
MRC1

mannose receptor C-type 1

4360

HGNC:7228

153007,26214,934
CYP2C9

cytochrome P450 family 2 subfamily C member 9

1559

HGNC:2623

155003,90314,924
CCN2

cellular communication network factor 2

1490

HGNC:2500

1621196,42314,905
STK11

serine/threonine kinase 11

6794

HGNC:11389

169006,04614,866
GDNF

glial cell derived neurotrophic factor

2668

HGNC:4232

1182007,67814,796
LGALS3

galectin 3

3958

HGNC:6563

11663145,57714,742
IRS1

insulin receptor substrate 1

3667

HGNC:6125

1117117,00814,719
ERBB3

erb-b2 receptor tyrosine kinase 3

2065

HGNC:3431

1279181905,98614,691
COMT

catechol-O-methyltransferase

1312

HGNC:2228

1934636,69314,671
EGR1

early growth response 1

1958

HGNC:3238

1127108,36214,658
S100B

S100 calcium binding protein B

6285

HGNC:10500

1105006,20414,655
NPM1

nucleophosmin 1

4869

HGNC:7910

110421345,44914,642
TARDBP

TAR DNA binding protein

23435

HGNC:11571

1172006,05214,640
CD24

CD24 molecule

100133941

HGNC:1645

1132006,61514,615

Request

GET /api/genes/v1

A gene symbol, alias or name, an NCBI Gene, HGNC, Ensembl or UniProt ID, or a drug's name or ChEMBL ID.

No key needed

Response

The first 2 of this page's 20 results. GET /api/genes/v1?page=25

{
  "data": {
    "total": 193990,
    "results": [
      {
        "id": "7428",
        "title": "VHL: von Hippel-Lindau tumor suppressor",
        "summary": "NCBI Gene 7428. 1 protein, 55 patents, 0 drugs, 0 trials, 5,850 NIH grants and 15,284 papers.",
        "record": "/library/genes/7428",
        "gene_id": 7428,
        "symbol": "VHL",
        "name": "von Hippel-Lindau tumor suppressor",
        "hgnc_id": "HGNC:12687",
        "counts": {
          "proteins": 1,
          "patents": 55,
          "drugs": 0,
          "trials": 0,
          "grants": 5850,
          "papers": 15284
        }
      },
      {
        "id": "5624",
        "title": "PROC: protein C, inactivator of coagulation factors Va and VIIIa",
        "summary": "NCBI Gene 5624. 1 protein, 149 patents, 2 drugs, 13 trials, 3,226 NIH grants and 15,233 papers.",
        "record": "/library/genes/5624",
        "gene_id": 5624,
        "symbol": "PROC",
        "name": "protein C, inactivator of coagulation factors Va and VIIIa",
        "hgnc_id": "HGNC:9451",
        "counts": {
          "proteins": 1,
          "patents": 149,
          "drugs": 2,
          "trials": 13,
          "grants": 3226,
          "papers": 15233
        }
      }
    ],
    "columns": [
      {
        "key": "symbol",
        "label": "Gene",
        "under": "name"
      },
      {
        "key": "id",
        "label": "NCBI Gene",
        "under": "hgnc_id"
      },
      {
        "key": "counts.proteins",
        "label": "Proteins"
      },
      {
        "key": "counts.patents",
        "label": "Patents"
      },
      {
        "key": "counts.drugs",
        "label": "Drugs"
      },
      {
        "key": "counts.trials",
        "label": "Trials"
      },
      {
        "key": "counts.grants",
        "label": "NIH grants"
      },
      {
        "key": "counts.papers",
        "label": "Papers"
      }
    ],
    "order": "Most papers first"
  },
  "release": "gene-search-2026-11-11-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ChEMBL, through Open Targets",
      "license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC BY-SA 3.0"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "None stated"
    },
    {
      "source": "EMBL-EBI's patent proteins",
      "license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
      "notice": null,
      "short": "No added restrictions. Attribution expected"
    },
    {
      "source": "GenBank's patent files",
      "license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
      "notice": null,
      "short": "No restrictions from NCBI. Submitters may hold rights"
    },
    {
      "source": "HGNC",
      "license": "CC0: https://www.genenames.org/about/license/",
      "notice": null,
      "short": "CC0"
    },
    {
      "source": "NCBI Gene",
      "license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
      "notice": null,
      "short": "None named. Public domain as US government information"
    },
    {
      "source": "NIH's project files and grant-paper links",
      "license": "Public domain (NIH RePORTER)",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "Open Targets",
      "license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC0 1.0"
    },
    {
      "source": "PubTator 3",
      "license": "Public domain",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "UniProt",
      "license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
      "notice": null,
      "short": "CC BY 4.0"
    }
  ],
  "next": "/api/genes/v1?page=26",
  "request_id": "l2zoFTzCk58BpGnN"
}
gene-search-2026-11-11-0.1.0Next page

Sources 11

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNone stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GeneNone named. Public domain as US government information
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Trial comparisons

ClinicalTrials.gov

Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.

Open85,013 comparisons2026-11-10

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Genes from software.

Every answer on this page is also JSON, under /api/genes/v1. No key.

GET https://conductscience.org/api/genes/v1?q=p53

Ask an assistant

  • Which drugs act on PCSK9, and which of their trials posted results?
  • How many patents list the exact protein sequence of TP53?
  • Which genes does evolocumab act on?
  • Which NIH grants have the most papers about APOE?